This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Pohang University of Science and Technology Foundation, Posco. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Eun-Ju Oh: Innovator in Biopharmaceutical Formulations
Introduction
Eun-Ju Oh is a prominent inventor based in Busan, South Korea. She has made significant contributions to the field of biopharmaceuticals, particularly in the development of long-acting formulations. Her innovative work has the potential to enhance therapeutic efficacy and patient outcomes.
Latest Patents
Eun-Ju Oh holds 1 patent for her invention titled "Long acting formulation of biopharmaceutical." This invention focuses on a long-acting formulation of biopharmaceuticals, specifically utilizing aptamer therapeutics. The formulation involves a branched PEGylated aptamer or a hyaluronic acid (HA) derivative, which is bioconjugated with a biopharmaceutical to produce a long-action formulation that regulates degradation in vivo.
Career Highlights
Throughout her career, Eun-Ju Oh has worked with notable institutions, including the Postech Academy-Industry Foundation and Posco. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Eun-Ju Oh has collaborated with esteemed colleagues such as Sei-Kwang Hahn and Hyun-Gu Kang. These partnerships have further enriched her research and innovation in biopharmaceutical formulations.
Conclusion
Eun-Ju Oh's contributions to the field of biopharmaceuticals exemplify her dedication to innovation and research. Her work on long-acting formulations has the potential to significantly impact therapeutic practices in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile